Ajanta Pharma Ltd. Fundamental & Technical Research, Share Price Today

NSE : AJANTPHARM
NIFTY : Nifty 500
NIFTY SECTOR : Nifty Pharma

About Company

Ajanta Pharma Limited is a specialty pharmaceuticals formulation company with a well-diversified Branded Generics business spread across India, the rest of Asia, and Africa. The company has a strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market. The company is committed to investing in innovative products to fill identified gaps and putting major capital allocation into this business. Ajanta’s business also consists of two more verticals: US Generics and Institutional business in Africa.

Market Cap. ₹32,292 Cr.

52 Week - High/Low ₹3,485/2,111

P/E Ratio 35.34

P/B Ratio 9.46

Enterprise Value ₹32,403 Cr.

ROE % 24.26

RSI Value 45.64

EMA 50 2656.07

EMA 200 2687.89

Net Profit 807 Cr.

Net Profit 3year growth 19.48 Cr.

Net Profit 3 year (back) 676 Cr.

Debt to Equity 0.0 %

EPS Growth TTM 14.09 %

Current Ratio 3.87 %

100 Day SMA 2,718 Rs.

200 Day SMA 2,856 Rs.

21 Day SMA 2,627 Rs.

50 Day SMA 2,613 Rs.

Book Value 273 Rs.

EV/EBITDA Ratio 24

QoQ EPS Growth 7 %

QoQ Operating Profit Growth 11 %

QoQ Sales Growth -2 %

Sales Latest Quarter 1,102 Cr.

YoY Sales Growth 2 %

Market Cap. ₹32,292 Cr.

52 Week - High/Low ₹3,485/2,111

P/E Ratio 35.21

P/B Ratio 9.05

Enterprise Value ₹32,202 Cr.

ROE % 23.49

RSI Value 45.64

EMA 50 2656.07

EMA 200 2687.89

Net Profit 816 Cr.

Net Profit 3year growth 4.09 Cr.

Net Profit 3 year (back) 654 Cr.

Debt to Equity 0.0 %

EPS Growth TTM 13.25 %

Current Ratio 3.04 %

100 Day SMA 2,718 Rs.

200 Day SMA 2,856 Rs.

21 Day SMA 2,627 Rs.

50 Day SMA 2,613 Rs.

Book Value 286 Rs.

EV/EBITDA Ratio 24

QoQ EPS Growth 8 %

QoQ Operating Profit Growth 3 %

QoQ Sales Growth -3 %

Sales Latest Quarter 1,146 Cr.

YoY Sales Growth 4 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages